Eversept Partners, LP
NEW YORK, NY · CIK 1697013 · 13F filing filed 2023-11-08
SEC-registered investment adviser since 2017 · limited partnership
- Assets managed$2.7bn
- Staff10 · 5 in investment roles
- Main clients (by assets)Private funds 99%, Mutual funds and ETFs 1%
- Private funds3 (3 hedge) · $2.3bn gross assets
- Websiteeversept.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityEVERSEPT PARTNERS, L.P. (US)
- Kindhedge funds, futures
- Others nearbyNew York, NY, San Francisco, CA
As an employer
- Offices in1 country
- Private fundshedge 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 4 |
| San Francisco, CAUnited States | 1 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Options: 7 call positions ($117.8m notional), 5 put positions ($264.8m notional) – listed below, not included above.
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $92.2m9.00% | Reduced -11.9k |
| UNITED THERAPEUTICS CORP DEL UTHR | $73.2m7.15% | Added +18.6k |
| HORIZON THERAPEUTICS PUB L HZNP | $71.0m6.93% | Added +279.6k |
| GLAXOSMITHKLINE PLC SPONSORED ADR | $69.9m6.83% | Added +335.0k |
| ASTRAZENECA PLC SPONSORED ADR | $67.4m6.58% | Added +275.1k |
| DANAHER CORPORATION DHR | $45.6m4.45% | Added +19.9k |
| SANOFI SNY | $44.0m4.30% | New |
| AVANTOR INC AVTR | $34.8m3.40% | Added +124.9k |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | $33.9m3.31% | Added +367.1k |
| COMMUNITY HEALTH SYS INC NEW CYH | $30.2m2.95% | Added +934.1k |
| SPDR SER TR XBI | $26.4m2.58% | New |
| ENVISTA HOLDINGS CORPORATION NVST | $25.4m2.48% | Added +89.7k |
| BIOGEN INC BIIB | $20.7m2.02% | Added +23.4k |
| ELEVANCE HEALTH INC ELV | $20.6m2.02% | Added +10.3k |
| AMARIN CORP PLC SPONS ADR NEW | $19.8m1.93% | Added +4.3m |
| CENTENE CORP DEL CNC | $19.8m1.93% | Added +114.5k |
| SYNDAX PHARMACEUTICALS INC SNDX | $19.1m1.87% | New |
| ARGENX SE ARGX | $18.6m1.82% | Added +26.0k |
| FATE THERAPEUTICS INC FATE | $18.0m1.76% | Added +270.5k |
| AMNEAL PHARMACEUTICALS INC AMRX | $17.5m1.71% | Added +2.8k |
| ABIOMED INC ABMD | $17.2m1.68% | New |
| NATERA INC NTRA | $16.9m1.65% | New |
| GUARDANT HEALTH INC GH | $16.4m1.60% | Added +193.2k |
| TANDEM DIABETES CARE INC TNDM | $15.2m1.48% | New |
| CELLDEX THERAPEUTICS INC NEW CLDX | $14.9m1.45% | Reduced -84.1k |
| XENON PHARMACEUTICALS INC XENE | $14.2m1.38% | Added +55.9k |
| R1 RCM INC COM | $12.4m1.21% | New |
| MARAVAI LIFESCIENCES HLDGS I MRVI | $12.1m1.18% | New |
| LANTHEUS HLDGS INC LNTH | $11.9m1.16% | New |
| ALNYLAM PHARMACEUTICALS INC ALNY | $11.5m1.13% | Added +26.1k |
| 908 DEVICES INC MASS | $9.7m0.95% | Added +253.3k |
| LIQUIDIA CORPORATION LQDA | $9.2m0.89% | Added +722.2k |
| QIAGEN NV SHS NEW | $9.0m0.88% | Reduced -2.8k |
| TARO PHARMACEUTICAL INDS LTD TARO | $8.0m0.78% | Added +104 |
| HEALTHEQUITY INC HQY | $7.8m0.76% | Reduced -17.1k |
| MERUS N V MRUS | $6.5m0.64% | Added +211.0k |
| ILLUMINA INC ILMN | $6.5m0.63% | Reduced -3.5k |
| HUMANA INC HUM | $5.2m0.51% | New |
| RADIUS HEALTH INC RDUS | $5.2m0.51% | Added +200.4k |
| VIRIDIAN THERAPEUTICS INC VRDN | $5.2m0.50% | Added +289.8k |
| AMICUS THERAPEUTICS INC FOLD | $5.1m0.50% | New |
| PUMA BIOTECHNOLOGY INC PBYI | $4.1m0.40% | Added +10.4k |
| GOSSAMER BIO INC GOSS | $3.9m0.38% | Added +93.6k |
| ANAPTYSBIO INC ANAB | $3.7m0.36% | Added +68.6k |
| IONIS PHARMACEUTICALS INC IONS | $3.2m0.31% | Reduced -72.5k |
| AFFIMED N V COM | $3.1m0.31% | New |
| AGILENT TECHNOLOGIES INC A | $2.4m0.24% | Added +1.0k |
| INTUITIVE SURGICAL INC ISRG | $1.7m0.17% | Added +428 |
| PERKINELMER INC RVTY | $1.5m0.14% | Added +505 |
| IQVIA HLDGS INC IQV | $1.3m0.13% | Reduced -53.5k |
| LABORATORY CORP AMER HLDGS COM NEW | $1.3m0.12% | Reduced -32.6k |
| AADI BIOSCIENCE INC WHWK | $1.2m0.12% | Reduced -50.0k |
| ICON PLC ICLR | $1.2m0.12% | Reduced -41.2k |
| DEXCOM INC DXCM | $1.1m0.11% | Reduced -99.1k |
| ZENTALIS PHARMACEUTICALS INC ZNTL | $1.1m0.11% | Reduced -61.8k |
| REPLIGEN CORP RGEN | $924.5k0.09% | Reduced -30.8k |
| MILESTONE PHARMACEUTICALS IN MIST | $905.1k0.09% | Unchanged |
| MASIMO CORP MASI | $781.9k0.08% | Reduced -203.0k |
| HESKA CORP HSKA | $734.5k0.07% | Added +1.9k |
| SHOCKWAVE MED INC SWAV | $630.9k0.06% | New |
| AC IMMUNE SA ACIU | $449.8k0.04% | Unchanged |
| SONIDA SENIOR LIVING INC SNDA | $319.4k0.03% | Unchanged |
| ELEDON PHARMACEUTICALS INC ELDN | $144.1k0.01% | Reduced -54.9k |
| BOLT BIOTHERAPEUTICS INC COM | $63.6k0.01% | New |
| GLYCOMIMETICS INC COM | $60.1k0.01% | Unchanged |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| ASCENDIS PHARMA A/S | $49.0m417.2k shares |
| R1 RCM INC RCM | $36.4m1.4m shares |
| HCA HEALTHCARE INC HCA | $27.9m111.4k shares |
| ARK ETF TR ARKG | $21.6m470.5k shares |
| MCKESSON CORP MCK | $16.1m52.4k shares |
| NANOSTRING TECHNOLOGIES INC NSTG | $9.8m280.7k shares |
| ORTHO CLINICAL DIAGNOSTICS H OCDX | $8.3m445.1k shares |
| SYNEOS HEALTH INC INCR | $6.6m81.4k shares |
| EXELIXIS INC EXEL | $4.6m203.2k shares |
| IRHYTHM TECHNOLOGIES INC IRTC | $4.3m27.0k shares |
| KARUNA THERAPEUTICS INC | $2.0m15.9k shares |
| MERCK & CO INC MRK | $2.0m9.5k shares |
| AUTOLUS THERAPEUTICS PLC AUTL | $1.5m371.5k shares |
| ENSIGN GROUP INC ENSG | $936.4k10.4k shares |
| KODIAK SCIENCES INC KOD | $704.1k91.2k shares |
| ASSEMBLY BIOSCIENCES INC | $576.8k280.0k shares |
| SPERO THERAPEUTICS INC SPRO | $518.9k59.6k shares |
| ADAPTIMMUNE THERAPEUTICS PLC ADAPY | $488.4k237.1k shares |
| SURGALIGN HOLDINGS INC RTIX | $478.9k1.6m shares |
| BIO-TECHNE CORP TECH | $459.9k1.1k shares |
| MEREO BIOPHARMA GROUP PLC MREO | $414.6k370.2k shares |
| CYCLERION THERAPEUTICS INC | $412.9k372.0k shares |
| AVROBIO INC | $389.9k295.4k shares |
| ORCHARD THERAPEUTICS PLC ORTX | $298.7k419.6k shares |
| CLOVIS ONCOLOGY INC CLVS | $60.6k30.0k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR S&P 500 ETF TR SPY · Put | $175.4m465.0k shares | New |
| INVESCO QQQ TR QQQ · Put | $75.7m270.0k shares | Added |
| GLAXOSMITHKLINE PLC Call | $67.6m1.6m shares | Unchanged |
| ASTRAZENECA PLC Call | $19.8m300.3k shares | Reduced |
| SPDR SER TR XBI · Call | $19.3m259.8k shares | New |
| ISHARES TR IWM · Put | $8.5m50.0k shares | New |
| CELLDEX THERAPEUTICS INC NEW CLDX · Call | $5.2m191.6k shares | New |
| MERCK & CO INC MRK · Call | $4.4m48.7k shares | Unchanged |
| ARK ETF TR ARKK · Put | $3.6m90.0k shares | New |
| CELLDEX THERAPEUTICS INC NEW CLDX · Put | $1.6m60.6k shares | New |
| COMMUNITY HEALTH SYS INC NEW CYH · Call | $750.0k200.0k shares | New |
| TEVA PHARMACEUTICAL INDS LTD Call | $698.6k92.9k shares | Unchanged |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 | 5.7%≈ $26.5m |